Tentative Date for FDA Advisory Panel Review of Cartiva SCI

FDA tentatively scheduled a 2Q16 meeting of the Orthopaedic and Rehabilitation Devices Panel to review Cartiva’s Premarket Approval Application for the Synthetic Cartilage Implant in the treatment of great toe osteoarthritis.